KEA 0447

Drug Profile

KEA 0447

Alternative Names: KRP-EPA-605

Latest Information Update: 08 Apr 2016

Price : $50

At a glance

  • Originator Kissei Pharmaceutical; Kyorin Pharmaceutical
  • Class Urologics
  • Mechanism of Action Prostaglandin-E EP1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Overactive bladder

Most Recent Events

  • 17 Oct 2013 Phase-I clinical trials in Overactive bladder in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top